Glazer Capital »

West Enclave Merger Corp shares owned by Glazer Capital

Quarter-by-quarter ownership of West Enclave Merger Corp shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in West Enclave Merger Corp

Tip: Access up to 7 years of quarterly data

All positions including West Enclave Merger Corp held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Enclave Merger Corp by Glazer Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $33k 193k 0.17

More positions owned by Glazer Capital

Topbuild Put Option
Penumbra Put Option (PEN)
Janus Henderson Group Ord Shs
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Select Medical Holdings Corporation
Catalyst Pharmaceutical Partners (CPRX)
HudBay Minerals (HBM)
Digitalbridge Group Cl A New (DBRG)
Chart Industries (GTLS)
Caesars Entertainment (CZR)
Esperion Therapeutics (ESPR)
Webster Financial Corporation (WBS)
Sila Realty Trust Common Stock
Cyberark Software Note 0% 06/15/2030 (Principal)

View all positions for Glazer Capital

Top funds holding West Enclave Merger Corp

Linden Advisors
Adage Capital Partners GP
Toronto-Dominion Bank
Polar Securities
CNH Partners
Parallax Volatility Advisers
Meteora Capital
Decagon Asset Management
Rivernorth Capital Management
Bnp Paribas Arbitrage, Snc
Tudor Investment Corporation
Glazer Capital
Clear Street Group
Mint Tower Capital Management B.V.
Radcliffe Capital Management

View all funds holding West Enclave Merger Corp